TY  - JOUR
AU  - Schneider-Futschik, Elena K
AU  - Reyes-Ortega, Felisa
PY  - 2021
DO  - 10.3390/pharmaceutics13081157
SN  - 1999-4923
UR  - https://hdl.handle.net/10668/28320
T2  - Pharmaceutics
AB  - Nanomaterials provide enormous opportunities to overcome the limitations of conventional ocular delivery systems, such as low therapeutic efficacy, side effects due to the systemic exposure, or invasive surgery. Apart from the more common ocular...
LA  - en
KW  - cystic fibrosis
KW  - magnetic diagnosis agents
KW  - magnetic nanoparticles
KW  - ocular cancer
KW  - ocular disorders
KW  - therapeutic agents
TI  - Advantages and Disadvantages of Using Magnetic Nanoparticles for the Treatment of Complicated Ocular Disorders.
TY  - research article
VL  - 13
ER  -